do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline Role of Dipeptidyl Peptidase 4 in Antidiabetic Treatment The Role of DPP-4 Inhibitors

GLP-1 agonists are one of a few classes of diabetes medications proven to have cardiovascular, renal and mortality benefit in large-scale prospective randomised controlled trials

In order to diagnose gastroparesis, a medical professional usually performs a gastric emptying study to confirm delayed stomach emptying and rule out mechanical obstruction

144 The study used a randomized, open-label design and employed magnetic resonance imaging technology (MRI-PDFF) to measure liver fat content (LFC) after 24 weeks of treatment

Clinical data are very limited

These results position mazdutide as superior to semaglutide for both glycemic control and weight loss